当前位置:首页 - 行情中心 - 力生制药(002393) - 财务分析 - 资产负债表

力生制药

(002393)

  

流通市值:48.64亿  总市值:50.07亿
流通股本:2.50亿   总股本:2.58亿

资产负债表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
流动资产:
货币资金1,668,160,052.291,638,999,235.41,558,525,139.481,597,539,990.01
应收票据及应收账款316,159,714.25263,431,840.79301,989,637.45333,349,611.51
其中:应收票据48,183,462.1255,467,055.4845,383,889.0242,440,741.38
应收账款267,976,252.13207,964,785.31256,605,748.43290,908,870.13
应收款项融资163,455,280.66163,151,561.9784,356,008.7981,062,576.04
预付款项39,828,149.0134,881,849.4748,943,57946,593,389.93
其他应收款合计29,052,801.973,208,494.9934,830,410.7630,073,825.01
存货223,279,537.3224,365,964.79227,492,014.85261,752,069.14
合同资产339,000448,011.63--
一年内到期的非流动资产55,354,583.3376,474,583.33--
其他流动资产120,357,625.481,397,145.3622,325,201.2472,480,208.21
流动资产平衡项目0000
流动资产合计3,066,995,612.163,059,714,286.072,990,313,562.362,992,374,093.93
非流动资产:
其他权益工具投资1,295,159,677.961,295,159,677.961,497,800,8021,498,012,405.19
其他非流动金融资产29,781,238.9429,781,238.9429,925,184.6129,925,184.61
投资性房地产29,863,726.3929,920,173.41-30,258,855.53
固定资产975,118,047.2988,136,931.031,019,252,891.761,009,979,359.03
在建工程18,221,280.9817,610,268.285,464,783.792,491,775.52
使用权资产13,462,768.2814,492,679.811,603,920.565,397,963.45
无形资产174,163,833.26184,059,237.19179,503,254.69179,783,913.5
商誉70,717,263.0470,717,263.0462,373,486.2362,373,486.23
长期待摊费用1,233,751.74923,739.36--
递延所得税资产41,639,821.4943,799,680.9333,559,058.8632,666,355.29
其他非流动资产59,718,498.2151,196,636.27186,878,740.06207,535,585.36
非流动资产平衡项目0000
非流动资产合计2,709,079,907.492,725,797,526.213,026,362,122.563,058,424,883.71
资产平衡项目0000
资产总计5,776,075,519.655,785,511,812.286,016,675,684.926,050,798,977.64
流动负债:
短期借款29,750,00039,790,877.0580,115,908.1860,891,215.51
应付票据及应付账款106,127,043.39135,842,070.5578,244,816.32103,101,815.29
其中:应付票据42,431,621.139,712,762.091,860,000-
应付账款63,695,422.2996,129,308.4676,384,816.32103,101,815.29
预收款项1,816,594.756,700,172.926,300,0006,300,000
合同负债14,077,899.0533,604,600.0810,123,053.2220,222,281.47
应付职工薪酬70,812,229.0759,074,239.3166,028,960.4165,389,188.53
应交税费51,356,550.6347,083,471.3545,798,719.6538,641,229.86
其他应付款合计430,382,170.22417,316,331.79456,330,486.94558,232,158.19
应付股利146,4001,500,0001,500,00058,680,607.8
一年内到期的非流动负债2,349,504.982,837,824.582,811,297.541,667,633.16
其他流动负债920,108.694,278,278.92727,966.111,668,113.01
流动负债平衡项目0000
流动负债合计707,592,100.78746,527,866.55746,481,208.37856,113,635.02
非流动负债:
租赁负债7,984,153.198,380,896.699,517,390.754,546,840.88
长期应付职工薪酬11,048,886.0110,998,886.0111,570,684.4811,498,184.48
预计负债10,383,736.59,904,598.334,451,400.23,990,221.94
递延收益27,837,791.3428,511,381.8227,718,284.7727,776,724.89
递延所得税负债181,791,065.17181,010,916.48213,639,688.66212,616,812.35
其他非流动负债202,074202,074513,872.05513,872.05
非流动负债平衡项目0000
非流动负债合计239,247,706.21239,008,753.33267,411,320.91260,942,656.59
负债平衡项目0000
负债合计946,839,806.99985,536,619.881,013,892,529.281,117,056,291.61
所有者权益(或股东权益):
实收资本(或股本)257,704,999257,895,388257,942,988257,942,988
资本公积1,609,510,826.721,652,258,443.161,650,119,577.951,650,119,577.95
减:库存股46,312,453.661,054,385.1622,593,32023,667,320
其他综合收益959,144,494.33960,365,549.791,134,997,168.971,147,267,223.06
专项储备18,908,662.5118,097,556.321,857,178.9520,755,154.89
盈余公积482,828,996.6482,828,996.6464,950,504.45463,742,422.51
未分配利润1,516,095,487.171,459,524,542.121,463,307,498.281,385,536,731.78
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计4,797,881,012.734,769,916,090.814,970,581,596.64,901,696,778.19
少数股东权益31,354,699.9330,059,101.5932,201,559.0432,045,907.84
股东权益平衡项目0000
股东权益合计4,829,235,712.664,799,975,192.45,002,783,155.644,933,742,686.03
负债和股东权益合计5,776,075,519.655,785,511,812.286,016,675,684.926,050,798,977.64
公告日期2025-04-252025-03-212024-10-302024-08-23
审计意见(境内)标准无保留意见
TOP↑